Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

5
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
5
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Hypoglycemia01:26

Hypoglycemia

5
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
5
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

5
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
5
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.2K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized cardiometabolic care powered by artificial intelligence.

Frontiers in endocrinology·2025
Same author

Safety of a Novel Continuous Glucose Monitoring-Informed Insulin Bolus Calculator Mobile Application for People With Type 1 or Type 2 Diabetes.

Diabetes spectrum : a publication of the American Diabetes Association·2025
Same author

Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patients.

Contemporary clinical trials communications·2025
Same author

The critical elements of digital health in diabetes and cardiometabolic care.

Frontiers in endocrinology·2024
Same author

The Development and Potential Applications of an Automated Method for Detecting and Classifying Continuous Glucose Monitoring Patterns.

Journal of diabetes science and technology·2024
Same author

Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.

JMIR diabetes·2023

Related Experiment Video

Updated: Apr 22, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K

Hypoglycemia prediction using machine learning models for patients with type 2 diabetes.

Bharath Sudharsan1, Malinda Peeples1, Mansur Shomali2

  • 1WellDoc, Inc, Baltimore, MD, USA.

Journal of Diabetes Science and Technology
|October 16, 2014
PubMed
Summary

Machine learning models can predict hypoglycemia in type 2 diabetes patients using limited self-monitored blood glucose (SMBG) data. These validated tools show high accuracy, potentially reducing dangerous low blood sugar events.

Keywords:
hypoglycemia predictionmachine learningtype 2 diabetes

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K

Related Experiment Videos

Last Updated: Apr 22, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K

Area of Science:

  • Diabetes Management
  • Artificial Intelligence in Healthcare
  • Clinical Prediction Models

Background:

  • Hypoglycemia is a significant risk for type 2 diabetes patients, often due to infrequent self-monitored blood glucose (SMBG) monitoring.
  • Current monitoring methods provide limited data, challenging timely intervention for preventing hypoglycemia.

Purpose of the Study:

  • To develop and validate machine learning models for predicting hypoglycemia in type 2 diabetes patients.
  • To assess the optimal frequency of SMBG readings required for accurate prediction.
  • To evaluate the impact of incorporating medication data on prediction accuracy.

Main Methods:

  • Trained probabilistic models using machine learning algorithms on patient SMBG data.
  • Defined hypoglycemia as SMBG < 70 mg/dL.
  • Validated models using multiple datasets and incorporated medication administration information into a second model.

Main Results:

  • The optimal number of weekly SMBG values for the model was approximately 10.
  • The model achieved 92% sensitivity and 70% specificity for predicting hypoglycemia within 24 hours.
  • Incorporating medication data improved specificity to 90% for predicting hypoglycemia within the hour.

Conclusions:

  • Machine learning models can effectively predict hypoglycemia in type 2 diabetes patients with high sensitivity and specificity.
  • These validated models, especially when incorporating medication data, can be valuable tools for real-time hypoglycemia risk reduction.
  • The findings suggest a potential improvement in patient safety and diabetes management through advanced predictive analytics.